Suchergebnisse - "Gonzalez-Rojas, Yaneicy"

PubPharm (12)

1

Donanemab in Early Symptomatic Alzheimer Disease : The TRAILBLAZER-ALZ 2 Randomized Clinical Trial

enthalten in: JAMA | 2023

von Sims, J. | Zimmer, J. | Evans, C. | +117

CommentIn: JAMA. 2023 Jul 17;:. - PMID 37459123

2

Intramuscular vs Intravenous SARS-CoV-2 Neutralizing Antibody Sotrovimab for Treatment of COVID-19 (COMET-TAIL) : A Randomized Noninferiority Clinical Trial

enthalten in: Open forum infectious diseases | 2023

von Shapiro, A. | Sarkis, E. | Acloque, J. | +25

3

Intramuscular Versus Intravenous SARS-CoV-2 Neutralizing Antibody Sotrovimab for Treatment of COVID-19 (COMET-TAIL): A Randomized Non-inferiority Clinical Trial

enthalten in: bioRxiv.org | 2023

von Shapiro, A. | Sarkis, E. | Acloque, J. | +25

4

Early Covid-19 Treatment With SARS-CoV-2 Neutralizing Antibody Sotrovimab

enthalten in: bioRxiv.org | 2022

von Gupta, A. | Gonzalez-Rojas, Y. | Juarez, E. | +19

5

Effect of Sotrovimab on Hospitalization or Death Among High-risk Patients With Mild to Moderate COVID-19 : A Randomized Clinical Trial

enthalten in: JAMA | 2022

von Gupta, A. | Gonzalez-Rojas, Y. | Juarez, E. | +65

6

Efficacy of Inhaled Ciclesonide for Outpatient Treatment of Adolescents and Adults With Symptomatic COVID-19 : A Randomized Clinical Trial

enthalten in: JAMA internal medicine | 2022

von Clemency, B. | Varughese, R. | Gonzalez-Rojas, Y. | +4

CommentIn: JAMA Intern Med. 2022 May 1;182(5):571-572. - PMID 35311912

7

Early Treatment for Covid-19 with SARS-CoV-2 Neutralizing Antibody Sotrovimab

enthalten in: The New England journal of medicine | 2021

von Gupta, A. | Gonzalez-Rojas, Y. | Juarez, E. | +57

CommentIn: N Engl J Med. 2022 Apr 14;386(15):1480. - PMID 35294996

8

Effect of the Neutralizing SARS-CoV-2 Antibody Sotrovimab in Preventing Progression of COVID-19: A Randomized Clinical Trial

enthalten in: bioRxiv.org | 2021

von Gupta, A. | Gonzalez-Rojas, Y. | Juarez, E. | +17

9

Ceftobiprole Compared With Vancomycin Plus Aztreonam in the Treatment of Acute Bacterial Skin and Skin Structure Infections : Results of a Phase 3, Randomized, Double-blind Trial (TARGET)

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2021

von Overcash, J. | Kim, C. | Keech, R. | +11

10

A randomized controlled trial of inhaled ciclesonide for outpatient treatment of symptomatic COVID-19 infections

enthalten in: bioRxiv.org | 2021

von Clemency, B. | Varughese, R. | Gonzalez-Rojas, Y. | +4